CYBB and persistent truncus arteriosus: In TAC-induced PAH mice model, SS-31 can inhibit the release of inflammatory factors and improve endothelial function by reducing the expression of pro-oxidant protein NOX1/NOX2, and reduce TAC-induced right ventricular systolic pressure [216].